One of Minnesota’s two medical cannabis producers has raised another $2.5 million, according to a filing with the U.S. Securities and Exchange Commission.
The raise, by LeafLine Labs, comes on top of $12.4 million the company landed late last year. To date, LeafLine has raised $14.9 million – just $176,000 short of its goal.
The other licensed company – Minnesota Medical Solutions, also known as MinnMed – closed a $16.6 million round of funding earlier this year.